98 related articles for article (PubMed ID: 843007)
1. Combination therapy in metastatic breast cancer.
Cziráki L; OO M
Ann Intern Med; 1977 Mar; 86(3):364-5. PubMed ID: 843007
[No Abstract] [Full Text] [Related]
2. [Combined leukeran-prednisolone therapy in metastasizing breast cancer].
Cziráki L; Oó M
Fortschr Med; 1977 Apr; 95(15):1043-6. PubMed ID: 858580
[No Abstract] [Full Text] [Related]
3. Adjuvant chemotherapy with chlorambucil and 5-fluorouracil in primary breast cancer (Cooperative Study Heidelberg).
Kaufmann M; Fournier DV; Sievers H; Staib I; Wöllgens P; Nedden R; Lochbühler H; Queisser W; Christmann D; Bühner R; Pfuhl PJ; Henningsen B; Kuttig H; Wysocki S; Thüre D; Köhler C; Drings P
Eur J Cancer (1965); 1980; Suppl 1():157-60. PubMed ID: 7032925
[No Abstract] [Full Text] [Related]
4. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
[No Abstract] [Full Text] [Related]
5. Combination chemotherapy with cyclophosphamide (NSC-26 271), methotrexate (NSC-740), and prednisolone (NSC-9 900) (CMP protocol), for metastatic breast cancer.
Umsawasdi T; Nilprabhassorn P
J Med Assoc Thai; 1978 Mar; 61(3):158-61. PubMed ID: 660008
[No Abstract] [Full Text] [Related]
6. [Cytostatic therapy of choroid membrane metastases].
Müller-Grotjan H; Liegl O
Klin Monbl Augenheilkd; 1966; 148(6):864-8. PubMed ID: 5987294
[No Abstract] [Full Text] [Related]
7. Combination chemotherapy of metastatic breast cancer with vincristine adriamycin and prednisolone.
Russell JA; Baker JW; Dady PJ; Ford HT; Gazet JC; McKinna JA; Nash AG; Powles TJ
Cancer; 1978 Feb; 41(2):396-9. PubMed ID: 630530
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy for thrombocytopenia with bone marrow metastases from breast cancer.
Dady PJ; Gazet JC; Ford HT; Powles TJ
Br Med J; 1977 Feb; 1(6060):554. PubMed ID: 843805
[No Abstract] [Full Text] [Related]
9. Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.
Jungi WF; Senn HJ; Amgwerd R; Hochuli E
Eur J Cancer (1965); 1980; Suppl 1():169-72. PubMed ID: 7032928
[No Abstract] [Full Text] [Related]
10. Response of metastatic breast cancer to combination chemotherapy according to site.
Russell JA; Baker JW; Dady PJ; Ford HT; Gazet JC; McKinna JC; Nash AG; Powles TJ
Br Med J; 1977 Nov; 2(6099):1390-1. PubMed ID: 589226
[No Abstract] [Full Text] [Related]
11. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
[No Abstract] [Full Text] [Related]
12. Treatment of membranous nephropathy with prednisolone and chlorambucil.
Mavromatidis C; Spaia S; Christidou F; Vayonas G
Lancet; 1989 May; 1(8645):1015. PubMed ID: 2565486
[No Abstract] [Full Text] [Related]
13. Secondary chemotherapy of advanced breast cancer.
Goldenberg IS; McMahan CA; Escher GC; Volk H; Ansfield FJ; Olson KB
Cancer; 1973 Mar; 31(3):660-3. PubMed ID: 4693595
[No Abstract] [Full Text] [Related]
14. Combined chemo- and hormonal therapy in advanced breast cancer.
Brunner KW; Sonntag RW; Alberto P; Senn HJ; Martz G; Obrecht P; Maurice P
Cancer; 1977 Jun; 39(6 Suppl):2923-33. PubMed ID: 326385
[No Abstract] [Full Text] [Related]
15. [Combined chemotherapy in metastatic breast cancer].
Haab OP
Praxis; 1967 Jun; 56(25):873-4. PubMed ID: 5632944
[No Abstract] [Full Text] [Related]
16. Letter: Chemotherapy after mastectomy.
Cavalli F; Alberto P; Jungi F; Martz G
Lancet; 1976 May; 1(7970):1185. PubMed ID: 58229
[No Abstract] [Full Text] [Related]
17. Acute leukemia complicating metastatic breast cancer.
Davis HL; Prout MN; McKenna PJ; Cole DR; Korbitz BC
Cancer; 1973 Mar; 31(3):543-6. PubMed ID: 4511910
[No Abstract] [Full Text] [Related]
18. Mitoxantrone, methotrexate and chlorambucil in metastatic breast cancer, a combination with relatively low subjective toxicity.
Burghouts JT
Neth J Med; 1990 Feb; 36(1-2):43-5. PubMed ID: 2314519
[TBL] [Abstract][Full Text] [Related]
19. A controlled study in the use of combined drug therapy for metastatic breast cancer.
Brunner KW; Sonntag RW; Martz G; Senn HJ; Obrecht P; Alberto P
Cancer; 1975 Oct; 36(4):1208-19. PubMed ID: 1175124
[TBL] [Abstract][Full Text] [Related]
20. [Experiences with cytostatic combination therapy in hormone-resistant metastasizing breast cancer].
Brunner KW
Schweiz Med Wochenschr; 1969 Sep; 99(36):1298-303. PubMed ID: 5351150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
